ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

デクスケトプロフェン

Dexketoprofen

HCID 667550
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
22161-81-5
標準SMILES
C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1
InChIKey
DKYWVDODHFEZIM-NSHDSACASA-N
分子式
C16H14O3
平均分子量
254.28 g/mol
単同位体質量
254.09429431

概要

Dexketoprofen is a monocarboxylic acid that is (S)-hydratropic acid substituted at position 3 on the phenyl ring by a benzoyl group. A cyclooxygenase inhibitor, it is used to relieve short-term pain, such as muscular pain, dental pain and dysmenorrhoea. It has a role as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, a cyclooxygenase 2 inhibitor and a cyclooxygenase 1 inhibitor. It is a member of benzophenones and a monocarboxylic acid. It is functionally related to a (S)-hydratropic acid.

名称と識別子

優先名称
Dexketoprofen
IUPAC
(2S)-2-(3-benzoylphenyl)propanoic acid
現地名
デクスケトプロフェン
英語名
(S)-(+)-Ketoprofen
分子式
C16H14O3
分子量
254.28

名称と別名

DEXKETOPROFEN22161-81-5(S)-Ketoprofen(+)-KetoprofenArveles(+)-3-Benzoylhydratropic acidHydratropic acid, m-benzoyl-, (+)-Ketoprofen, (s)-(+)-(S)-m-Benzoylhydratropic aciddexketoprofeneDexketoprofeno(S)-3-Benzoyl-alpha-methylbenzeneacetic acid
名称をさらに表示
(S)-2-(3-ベンゾイルフェニル)プロパン酸(αS)-α-メチル-3-ベンゾイルベンゼン酢酸(S)-ケトプロフェンデクスケトプロフェン(S)-3-ベンゾイル-α-メチルベンゼン酢酸(2S)-2-(3-ベンゾイルフェニル)プロピオン酸(2S)-2-(3-ベンゾイルフェニル)プロパン酸(S)-α-メチル-3-ベンゾイルベンゼン酢酸(S)-2-(3-ベンゾイルフェニル)プロピオン酸(S)-(+)-ケトプロフェン(2S)-2-(3-Benzoylphenyl)propanoic acidKeralDexktoprofenDexketoprofeexketoprofenlevoketoprofenDexketoprofen API
6KD9E78X68CHEBI:76128DTXSID40905141Benzeneacetic acid, 3-benzoyl-alpha-methyl-, (S)-dexketoprofen sodiumdexketoprofenumRefChem:132392M01AE17

物性

構造計算による物性

XLogP
3.1
極性表面積
54.4 Ų
水素結合供与体数
1
水素結合受容体数
3
回転可能結合数
4
重原子数
19
形式電荷
0
複雑度
331

物理化学的性質

融点
75 · 75-78 °C(lit.)
沸点
431.3 · 431.3±28.0 °C(Predicted)
比重(密度)
1.198 · 1.198±0.06 g/cm3(Predicted)
貯蔵温度
Sealed in dry,Room Temperature
溶解性
2 O; · insoluble in H2O; ≥10.6 mg/mL in DMSO; ≥20.55 mg/mL in EtOH
酸解離定数(Pka)
4.23 · 4.23±0.10(Predicted)
外見
白い固体。
色
White to off-white
InChI
InChI=1/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)/t11-/s3
InChIKey
DKYWVDODHFEZIM-LBPXTSNRNA-N
SMILES
C1(=CC=CC([C@H](C)C(=O)O)=C1)C(=O)C1=CC=CC=C1 |&1:5,r|
CAS データベース
22161 · 22161-81-5(CAS DataBase Reference)

化学的性質

化学的特性White Solid

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 5 件

This chemical does not meet GHS hazard criteria for 2.4% (1 of 42) of reports.

Danger

H301 (97.6%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P273, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 42 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory InformationStatus: Active Update: 06-11-2019 https://echa.europa.eu/registration-dossier/-/registered-dossier/17708
Hazard Classes and CategoriesAcute Tox. 3 (97.6%)

毒性情報

Drug Induced Liver Injury · 4 件

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

DEXKETOPROFEN

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

安全データ

wgk
3
rtecs
CY1572790
ridadr
UN 2811 6.1/PG 3
risk_code
22-36/37/38-50/53-25
hazard_code
Xn,T
safety_code
26-60-61-45
Hazard Classifications
Acute Tox. 3 OralAquatic Acute 1Eye Irrit. 2Skin Irrit. 2STOT SE 3

化学と産業

薬理情報

ATC Code · 4 件

M - Musculo-skeletal system

M - Musculo-skeletal system

QM - Musculo-skeletal system

QM - Musculo-skeletal system

Protein BindingHighly protein bound.
PharmacodynamicsThis drug is an isomer of ketoprofen. Dexketoprofen a propionic acid derivative with analgesic, anti-inflammatory, and antipyretic properties.
Mechanism of ActionIt is a non-steroidal anti-inflammatory drug (NSAID) that reduces prostaglandin synthesis via inhibition of cyclooxygenase pathway (both COX-1 and COX-2) activity.
Biological Half-Life1.65 h
Metabolism/Metabolites · 1 件

Dexketoprofen is highly lipophilic, and is metabolized in the liver by glucuronidation. In one study, after oral administration of 25 mg of dexketoprofen to young healthy adults, Tmax was approximately 30 min for a Cmax of 3.7 ± 0.72 mg/l. Dexketoprofen trometamol is metabolized by the hepatic cytochrome P450 enzymes (CYP2C8 and CYP2C9). Dexketoprofen trometamol has a number of metabolites, with hydroxyl derivatives making up the greatest volume. In humans, hydroxylation plays a minor role. Dexketoprofen is primarily conjugated to an acyl-glucuronide

MeSH Pharmacological Classification · 1 件

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Absorption, Distribution and Excretion · 4 件

関連反応

8 件
反応記録を作成
HRID 650619 の反応式
HRID 650619反応物として
HRID 1459039 の反応式
HRID 1459039生成物として
HRID 1459041 の反応式
HRID 1459041生成物として
HRID 1459042 の反応式
HRID 1459042生成物として
HRID 1459043 の反応式
HRID 1459043生成物として
HRID 1459044 の反応式
HRID 1459044生成物として
HRID 1459045 の反応式
HRID 1459045生成物として
HRID 1459046 の反応式
HRID 1459046生成物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
22161-81-5
PubChem CID
667550
DTXSID
DTXSID40905141
ChEMBL
CHEMBL75435
ChEBI
CHEBI:76128
UNII
6KD9E78X68
EC Number
606-944-5
Nikkaji
J389.200J
ストレージクラス
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects

After oral ingestion, the Dexketoprofen onset of action is within 30 minutes. The plasma half-life of Dexketoprofen is about 4-6 hours. The Cmax is about 30 minutes

Approximately 70 to 80% of the ingested dose is recovered in the urine during the first 12 hours post-ingestion, mainly as the acyl-conjugated form of the drug.

<0.25 L/kg

Mainly cleared via glucuronide conjugation and followed by renal excretion, mainly unchanged.

Cellular LocationsMembrane

応用分野

使用Anti-inflammatory; analgesic

補足説明 · 1 件

定義ChEBI: A monocarboxylic acid that is (S)-hydratropic acid substituted at position 3 on the phenyl ring by a benzoyl group. A cyclooxygenase inhibitor, it is used to relieve short-term pain, such as muscular pain, dental pain and dysmenorrhoea.